Bismarck Christian Odei
( out of 36 reviews )

Bismarck Christian Odei, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Dr Bismarck Odei is a physician-scientist and an Assistant Professor in Genitourinary Cancers at the Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah. He completed his undergraduate degree in Chemical Engineering at Brigham Young University. He subsequently completed his medical training at UCLA School of Medicine in Los Angeles, California. He was a resident and chief resident at The Ohio State Department of Radiation Oncology.

    Dr Odei is passionate about the success of his patients, and he is committed to effective patient care and education, and implementation of safe and cutting-edge technology to improve patient outcomes.

    Dr Odei's research interests include optimization of genitourinary cancer treatments, understanding the role of radiotherapy and hormone therapy in recurrent or metastatic prostate cancer, incorporating biomarker use for prognostication and predictive evaluation in prostate/bladder cancers, and the utilization of artificial intelligence for synthesizing molecular signatures to inform clinic management decisions. His non-cancer related research work focuses on equity in the academic workforce and health equity.

    He is the recent recipient of the 2023 University of Utah GUCC Pilot Grant for prostate cancer research, and the highly-competitive Robert A. Winn Career Development Award, supported by the Bristol Myers Squibb Foundation.

    Dr Odei's work has been published in premier medical journals such as JAMA Internal Medicine, JAMA Network Open, and International Journal of Radiation Oncology, Biology, and Physics. He has presented his research at international conferences such as the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), and National Medical Association (NMA). Some of his research work has scored in the top 5% of all research outputs scored by Altmetric.

    Outside of work he enjoys spending time with his wife and daughters, playing chess, and volunteers in religious and community events.

    Specialties

    Board Certification

    American Board of Radiology (Radiation Oncology)

    Patient Rating

    5.0 /5
    ( out of 36 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    HUNTSMAN CANCER CENTER

    Didn't see hime today. But he has been available and forthright.

    HUNTSMAN CANCER CENTER

    The Best

    SUGAR HOUSE HEALTH CENTER

    Dr Bismarc Odei was very informative and very compassionate and we felt like he was not rushed and spent time answering all our questions.

    SUGAR HOUSE HEALTH CENTER

    Professional, medically inclined, effective, effective listener, totally awesome!

    HUNTSMAN CANCER CENTER

    Caring and compassionate physician. Highly recommend.

    SUGAR HOUSE HEALTH CENTER

    Dr. Odei is one of the best Doctors I have met. I have every confidence in him.

    HUNTSMAN CANCER CENTER

    Very professional, very knowledgeable, all-around good guy

    HUNTSMAN CANCER CENTER

    Brilliant and caring!

    SUGAR HOUSE HEALTH CENTER

    I am glad I listened to him

  • Dr Bismarck Odei is a physician-scientist and an Assistant Professor in Genitourinary Cancers at the Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah. He completed his undergraduate degree in Chemical Engineering at Brigham Young University. He subsequently completed his medical training at UCLA School of Medicine in Los Angeles, California. He was a resident and chief resident at The Ohio State Department of Radiation Oncology.

    Dr Odei is passionate about the success of his patients, and he is committed to effective patient care and education, and implementation of safe and cutting-edge technology to improve patient outcomes.

    Dr Odei's research interests include optimization of genitourinary cancer treatments, understanding the role of radiotherapy and hormone therapy in recurrent or metastatic prostate cancer, incorporating biomarker use for prognostication and predictive evaluation in prostate/bladder cancers, and the utilization of artificial intelligence for synthesizing molecular signatures to inform clinic management decisions. His non-cancer related research work focuses on equity in the academic workforce and health equity.

    He is the recent recipient of the 2023 University of Utah GUCC Pilot Grant for prostate cancer research, and the highly-competitive Robert A. Winn Career Development Award, supported by the Bristol Myers Squibb Foundation.

    Dr Odei's work has been published in premier medical journals such as JAMA Internal Medicine, JAMA Network Open, and International Journal of Radiation Oncology, Biology, and Physics. He has presented his research at international conferences such as the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), and National Medical Association (NMA). Some of his research work has scored in the top 5% of all research outputs scored by Altmetric.

    Outside of work he enjoys spending time with his wife and daughters, playing chess, and volunteers in religious and community events.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Assistant Professor
    Board Certification
    American Board of Radiology (Radiation Oncology)

    Education history

    Undergraduate Chemical Engineering - Brigham Young University B.S.
    Professional Medical Medicine - David Geffen School of Medicine at UCLA M.D.
    David Geffen School of Medicine at UCLA Research Fellow
    Internship Sanford Medical Center Transitional Internship (UND) Transitional Internship
    Residency Ohio State University College of Medicine (Radiation Oncology) Resident
    Residency Ohio State University College of Medicine (Radiation Oncology) Chief Medical Resident

    Selected Publications

    Journal Article

    1. Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK (2018). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. Am J Clin Oncol, 41(8), 784-791. (Read full publication)
    2. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney D (2016). Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecologic oncology, 143(3), 690-691. (Read full publication)
    3. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney D (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecologic oncology, 141(3), 421-427. (Read full publication)
    4. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe M (2017). Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. International journal of radiation oncology, biology, physics, 97(1), 60-63.
    5. Boothe D, Williams N, Odei B, Poppe MM, Werner TL, Suneja G, Gaffney D (2017). The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care. International journal of gynecological cancer, 27(5), 912-922. (Read full publication)
    6. Odei BC, Boothe D, Lloyd S, Gaffney D (2016). A comprehensive analysis of brachytherapy clinical trials over the past 15 years. Brachytherapy, 15(6), 679-686. (Read full publication)
    7. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney D (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia, 17(12), 819-824. (Read full publication)
    8. Xiao H, Odei B, Clinton S, Mitchell (2021). The potential role of DEK over-expression in the radiation response of head and neck cancer. Radiation medicine and protection,
    9. Odei BC, Seldon C, Fernandez M, Rooney MK, Bae J, Acheampong J, Ahmed (2021). Representation of Women in the Leadership Structure of the US Health Care System. JAMA network open, 4(11), e2136358. (Read full publication)
    10. Odei B, Kahn J, Holliday EB, Diaz DA, Bello-Pardo E, Odei J, Bae J, Arnett A, Raval R, Mitchell (2021). Where Are the Women in Radiation Oncology? A Cross-Sectional Multi-Specialty Comparative Analysis. Advances in radiation oncology, 6(5), 100735. (Read full publication)
    11. Odei BC, Chino F, Mitchell (2021). A Charge to Academic Chairs-Reply. JAMA internal medicine, 181(8), 1136-1137. (Read full publication)
    12. Odei BC, Jagsi R, Diaz DA, Addison D, Arnett A, Odei JB, Mitchell (2021). Evaluation of Equitable Racial and Ethnic Representation Among Departmental Chairs in Academic Medicine, 1980-2019. JAMA network open, 4(5), e2110726. (Read full publication)
    13. Odei BC, Gawu P, Bae S, Fabian D, Odei J, Lee C, Mitchell (2021). Evaluation of Progress Toward Gender Equity Among Departmental Chairs in Academic Medicine. JAMA internal medicine, 181(4), 548-550. (Read full publication)
    14. Odei B, Holliday EB, Jagsi R, Chino F, Schulmire C, Kudrimoti M, Chen AM, Raval R, Fabian (2021). Recruitment Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. International journal of radiation oncology, biology, physics, 109(2), 637-638. (Read full publication)
    15. Odei B, Das P, Pinnix C, Raval R, Holliday E (2020). Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology. Advances in radiation oncology, 6(1), 100524. (Read full publication)
    16. Odei B, Quick (2020). The implications of COVID-19 in radiation oncology in the United States. Current oncology (Toronto, Ont.), 27(5), 279-280. (Read full publication)
    17. Odei B, Rwigema JC, Eilber FR, Eilber FC, Selch M, Singh A, Chmielowski B, Nelson SD, Wang PC, Steinberg M, Kamrava (2018). Predictors of Local Recurrence in Patients With Myxofibrosarcoma. American journal of clinical oncology, 41(9), 827-831. (Read full publication)
    18. Odei BC, Pan X, Bello-Pardo E, Mitchell D, Thomas CR Jr, Diaz D (2022). Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists. American journal of clinical oncology, 45(3), 112-115. (Read full publication)
    19. Odei BC, Herrera S, Huang C, Griffith KA, Bae J, Lastra AZ, Jagsi (2023). Portrayal of Women as Physicians in Movies, 1990-2020. JAMA internal medicine, 183(10), 1168-1170. (Read full publication)
    20. Hutten RJ, Odei B, Johnson SB, Tward J (2024). Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers. JCO precision oncology, 8, e2300364. (Read full publication)
    21. Sujay Kalathoor, Sanam Ghazi, Beryl Otieno, Melissa A. Babcook, Sunnia Chen, Neha Nidhi, Junu Bae, Jovan Pierre-Charles, Khadijah Breathett, Sula Mazimba, Amber Johnson, LaPrincess Brewer, Selma Mohammed, Rebecca R. Carter, Janice M. Bonsu, Mussammat Ferdousi, Onaopepo Kola-Kehinde, Eric McLaughlin, Jonathan Brammer, Patrick Ruz, Sarah Khan, Bismarck Odei, Darrion Mitchell, Lai Wei, Prem Patel, Electra D. Paskett, Daniel Addiso (2024). Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies. International Journal of Cancer,

    Review

    1. Anaba U, Ishola A, Alabre A, Bui A, Prince M, Okafor H, Kola-Kehinde O, Joseph JJ, Mitchell D, Odei BC, Uzendu A, Williams KP, Capers Q 4th, Addison (2022). Diversity in modern heart failure trials: Where are we, and where are we going. International journal of cardiology, 348, 95-101. (Read full publication)

    Commentary

    1. Odei BC, Mitchell (2023). The Asian Glass Ceiling in Academic Medical Leadership. International journal of radiation oncology, biology, physics, 116(2), 213. (Read full publication)

    Editorial

    1. Odei BCL, Boothe D, Keole SR, Vargas CE, Foote RL, Schild SE, Ashman J (2017). A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy. International journal of particle therapy, 3(3), 398-406. (Read full publication)
    2. Hutten RJ, Odei B, Rivera A, Suneja (2022). Achieving Health Equity in Radiation Oncology-Moving From Awareness to Action. International journal of radiation oncology, biology, physics, 114(2), 195-197. (Read full publication)

    Letter

    1. Odei BC, Bae J, Littman D, Lastra AZ, Morgan A, Agabalogun T, Herrera S, Odei J, Fabian D, Chino (2021). Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. International journal of radiation oncology, biology, physics, 110(3), 919-921. (Read full publication)
    2. Odei B, Bae S, Diaz D (2021). Challenges influencing the utilization of prostate brachytherapy in the United States. Radiotherapy and oncology, 154, 123-124. (Read full publication)

  • News & Podcasts

    Huntsman Cancer Institute News